Ophthalmology

The AJMC® Ophthalmology compendium is a comprehensive resource for clinical news and expert insights for treatment of disorders of the eye.

Latest News

GLP-1s | Image credit: Patrick Bay Damstead - stock.adobe.com
Use of GLP-1 RAs Associated With Increased Risk of NAION in Patients With Diabetes

August 6th 2025

Results confirm previous findings that nonarteritic anterior ischemic optic neuropathy (NAION) was more likely in those who used semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA).

Mina Massaro-Giordano, MD
Patients With Dry Eye Have More Treatment Options Than Ever Before: A Q&A With Mina Massaro-Giordano, MD

July 18th 2025

Man using eye drops | Image credit: 9nong - stock.adobe.com
Dry Eye Awareness Month Highlights Condition Affecting Millions

July 8th 2025

Man applying eye drops | Image credit: StockImageFactory
Education Surrounding Dry Eye a Persistent Barrier in Treatment

July 8th 2025

Targeting Tear Evaporation: How Perfluorohexyloctane Ophthalmic Solution Redefines the Management of Evaporative Dry Eye Disease
Targeting Tear Evaporation: How Perfluorohexyloctane Ophthalmic Solution Redefines the Management of Evaporative Dry Eye Disease

July 7th 2025

Continuing Medical Education
View All
August 12th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
August 12th 2025

The Evolving Strategies for Managing nAMD and DME: Empowering Managed Care Decisions for Improved Patient Outcomes

1.5 Credits / Endocrinology, Diabetes & Metabolism, Ophthalmology/Optometry
August 12th 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health
August 12th 2025

Harnessing Data-Driven Insights and Innovations to Enhance AMD and DME Management: Strategic Approaches for Managed Care

1.5 Credits / Ophthalmology/Optometry
August 12th 2025

Advancing Care in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Optimizing Outcomes With Emerging Therapies

1.5 Credits / Ophthalmology/Optometry
August 12th 2025

Leveraging Novel Therapies to Transform Demodex Blepharitis Care (Pharmacy Technician Credit)

1.5 Credit / Ophthalmology/Optometry
August 12th 2025

Leveraging Novel Therapies to Transform Demodex Blepharitis Care

1.5 Credit / Ophthalmology/Optometry

More News

Clinical Considerations for Retreatment in Failed Anti-VEGF Therapy
March 2nd 2023

Clinical Considerations for Retreatment in Failed Anti-VEGF Therapy

Veeral Sheth, MD, MBA, FACS discusses re-treatment in patients with wet AMD who have previously failed an anti-VEGF therapy.
Faricimab Approved Label Dosing Interval
March 2nd 2023

Faricimab Approved Label Dosing Interval

Dr Coney expands on the role and impact of approved label dosing of faricimab.
Eye with technology overlay
March 2nd 2023

Amsler Grid Test Not Recommended for Early AMD Detection

Julia Bonavitacola
A recent review found that the performance of the Amsler grid test was not at a level that was recommended for detecting early or dry age-related macular degeneration (AMD).
Baby in mother's arms
March 1st 2023

Cataract Surgery in Children Commonly Led to Glaucoma-Related Adverse Events

Julia Bonavitacola
The Pediatric Eye Disease Investigator Group collected data on children who had lensectomy prior to age 13 years in a 5-year span.
Richard Allen, MD, PhD, FACS
February 24th 2023

Dr Richard Allen Discusses Oculoplastic Surgery in Pediatric Patients

Skylar Jeremias Julia Bonavitacola
Richard Allen, MD, PhD, FACS, professor at Baylor College of Medicine, reviewed the challenges of oculoplastic surgery in pediatric patients.
Faricimab: Mechanism of Action, Payers’ Perspective, and Real-World Experience
February 23rd 2023

Faricimab: Mechanism of Action, Payers’ Perspective, and Real-World Experience

Key opinion leaders discuss faricimab, its impact on the treatment landscape for wet AMD/DME, and what payers should look for when considering formulary positioning or utilization-management strategies.
Variability of Frequency Dosing for Anti-VEGF Agents in the Treatment of Wet AMD
February 23rd 2023

Variability of Frequency Dosing for Anti-VEGF Agents in the Treatment of Wet AMD

Dr Coney discusses the variability of frequency dosing with anti-VEGF therapy in patients with wet AMD and DME, and Dr Sheth expands on Ang-2 and its contribution to the development of vascular instability in wet AMD.
Older woman's eye
February 22nd 2023

Visual Impairment Associated With Negative Effects on Older Adults With Dementia

Julia Bonavitacola
A review found that visual impairment is common in older adults with dementia and associated with negative effects.
Red FDA Approved stamp
February 17th 2023

FDA Approves First Treatment for Geographic Atrophy

Laura Joszt, MA
Geographic atrophy is a leading cause of blindness. The new approval will help to fill an unmet need for patients.
Anti-VEGF and Gene Therapy Impacting Wet AMD and DME Treatment Landscapes
February 16th 2023

Anti-VEGF and Gene Therapy Impacting Wet AMD and DME Treatment Landscapes

Dr Sheth discusses his insights on anti-VEGF therapy that he has noticed in the treatment of wet AMD over the last decade, and Caesar Luo, MD, FASRS, FACS shares his insight on new treatment options and their impact on patient access and cost considerations.
Important Considerations Regarding Treatment Selection for Wet AMD and DME Patient Populations
February 16th 2023

Important Considerations Regarding Treatment Selection for Wet AMD and DME Patient Populations

Dr Coney and Veeral Sheth, MD, MBA, FACS, FASRS, discuss treatment selection, treatment goals, and unmet needs for patients diagnosed with wet AMD and DME.
Woman using eyedrops
February 14th 2023

Atropine Eyedrops Associated With Lower Incidence of Myopia, Myopic Shift

Julia Bonavitacola
A nightly use of 0.05% atropine eyedrops resulted in a lower incidence of myopia compared with placebo.
Michael Cohen, MD, FAAO
February 9th 2023

Dr Michael Cohen Discusses Accessibility of Future Gene Therapies

Skylar Jeremias Julia Bonavitacola
Michael N. Cohen, MD, FAAO, retinal surgeon at Wills Eye Hospital in Philadephia and Mid Atlantic Retina, speaks about the future of gene therapy and the accessibility and availability of these therapies moving forward.
How Do the Patient Populations Differ for Wet AMD vs DME?
February 9th 2023

How Do the Patient Populations Differ for Wet AMD vs DME?

Joseph Coney, MD, FASRS, FACS, discusses the difference between population groups in age-related macular degeneration (AMD) and diabetic macular edema (DME)
Overview of Wet Age-Related Macular Degeneration (AMD) and Diabetic Macular Edema (DME)
February 9th 2023

Overview of Wet Age-Related Macular Degeneration (AMD) and Diabetic Macular Edema (DME)

Jim Kenney, RPh, MBA, opens a discussion surrounding wet age-related macular degeneration (AMD) and diabetic macular edema (DME).
Eye
February 6th 2023

Disparities in Pediatric Ophthalmology Have Increased

Julia Bonavitacola
Disparities in access to pediatric ophthalmological care is associated with lower socioeconomic status.
Eye
January 30th 2023

Vision Impairment Found in More Than a Quarter of Older US Adults

Julia Bonavitacola
A recent study has found that the prevalence of vision impairment in US adults 71 years and older was higher in 2021 compared with prior estimates.
Dr Michael Chiang Speaks About the NEI's Involvement in AMD, Addressing Health Disparities
January 26th 2023

Dr Michael Chiang Speaks About the NEI's Involvement in AMD, Addressing Health Disparities

Skylar Jeremias Julia Bonavitacola
Michael Chiang, MD, director of the National Eye Institute, spoke about efforts to address age-related macular degeneration (AMD) as well as health disparities in clinical trials and access to treatment.
Close up of eye
January 23rd 2023

Increased Incident CVD Risk Associated With RNFL Thinning

Julia Bonavitacola
Retinal nerve fiber layer (RNFL) thickness has been independently associated with incident cardiovascular disease risks in a new analysis that utilized data from 2 international databases.
Eye of an older woman
January 16th 2023

Hydroxychloroquine Dose Associated With Greater Risk of Incident Retinopathy

Julia Bonavitacola
Patients who took hydroxychloroquine had an overall risk of hydroxychloroquine retinopathy of 8.6% after 15 years.
Human eye
January 11th 2023

Cognitive Stages Leading to Dementia Appear Linked With Differences in Retinal Vasculature

Julia Bonavitacola
Retinal vasculature in peripheral regions of the retina differed in patients with Alzheimer dementia and mild cognitive impairment.
Eye
January 10th 2023

Improvements in AI Make Ocular Surface Disease Diagnosis Possible

Julia Bonavitacola
Diagnosing ocular surface diseases could be made easier as artificial intelligence (AI) screening improves.
Eye
January 3rd 2023

Metformin, Lifestyle Changes Not Associated With Risk of AMD

Julia Bonavitacola
A clinical trial found that the prevalence of age-related macular degeneration (AMD) was not associated with the use of metformin.
The Top 5 Ophthalmology Articles of 2022
December 31st 2022

Top 5 Most-Read Ophthalmology Content of 2022

Julia Bonavitacola
The top 5 most-read content in ophthalmology for 2022 focused on the relationship between aging and visual field reliability, telehealth eye care visits, the link between COVID-19 and dry eye disease, and more.
Eye
December 28th 2022

ICYMI: Top Content From AAO 2022

Julia Bonavitacola
Coverage of the annual meeting of the American Academy of Ophthalmology (AAO) included interviews with experts on thyroid eye disease and anti–vascular endothelial growth factor therapy, as well as breaking research.
Child holding his head
December 20th 2022

Symptoms of DED Have Increased in Pediatric Population Due to Screen Time

Julia Bonavitacola
A new study has found that prolonged screen time may cause increased symptoms of dry eye disease (DED) in children.
Eye
December 9th 2022

Ganglion Cell Complex Thinning Associated With Faster Central Visual Field Decline

Julia Bonavitacola
A retrospective cohort study found that rapid thinning of the ganglion cell complex was associated with central visual field decline.
Woman's eyes
December 6th 2022

Intense Pulsed Light Shows Promise as Treatment for Gland Dysfunction Causing Dry Eye

Julia Bonavitacola
Meibomian gland dysfunction, an etiological factor of dry eye disease, showed promising results in response to treatment with intense pulsed light.
Close up of older woman's eye
December 1st 2022

Gene Variants That Protect Against Alzheimer Disease Could Increase Risk of AMD

Julia Bonavitacola
The risk of age-related macular degeneration (AMD) could be linked to structural variations in the APOE gene that were previously found to be associated with protection against Alzheimer disease.
What We're Reading
November 22nd 2022

What We’re Reading: Global Oral Health Status Report; Predictive Value of Cholesterol Varies by Race; Disparities for People With Impaired Vision

AJMC Staff
A report from the World Health Organization highlights the global burden of oral diseases; study shows the predictive value of a “good” cholesterol level varies between Black and White patients; CDC report suggests people with impaired vision are not receiving proper health care.
<1
...
34567891011
...
19>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo